ZF7-27199-44278
4 vaccinations
2 coded responses
38 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 787 / TX
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-20
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
-
2021-10-16
Survey response — day 21, dose 3MedDRA: Discharge, Swelling, Tenderness, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Swelling randomly under ear for a few days followed by gross drainage in left molar area. No pain only tender to touch. This was before last checking but didn't think related so didn't mention. Progressively less drainage · Healthcare visit (other): Unable to get ENT appt primary care recommendedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-24
Survey response — day 28, dose 3MedDRA: Arthropathy, Mobility decreased, Muscular weakness — Feeling: Good · Be unable to do your normal daily activitiesFree text: Again I didn't connect it but since vaccine intermittent weakened muscles, joints Some days fine and others can't get up from floor without assistanceMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-30
- 2021-11-06
- 2021-12-28
- 2022-03-28
-
2022-04-22
Dose 4 — Pfizer-BioNTech
- 2022-05-14
- 2022-05-20
- 2022-06-03
- 2022-07-22
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-16 | Successful 2021-10-26 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — day 21, dose 3
Symptoms: Swelling randomly under ear for a few days followed by gross drainage in left molar area. No pain only tender to touch. This was before last checking but didn't think related so didn't mention. Progressively less drainage
Healthcare visit (other): Unable to get ENT appt primary care recommended
Release 10 — day 28, dose 3
Symptoms: Again I didn't connect it but since vaccine intermittent weakened muscles, joints Some days fine and others can't get up from floor without assistance
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthropathy | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Swelling | · | · | ✓ |
| SD | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release